Cerevel Therapeutics Holdings, Inc. (CERE)
NASDAQ: CERE · IEX Real-Time Price · USD
42.27
-0.11 (-0.26%)
At close: Mar 28, 2024, 4:00 PM
42.31
+0.04 (0.09%)
After-hours: Mar 28, 2024, 6:38 PM EDT
CERE Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for CERE stock have an average target of 40.36, with a low estimate of 30 and a high estimate of 45. The average target predicts a decrease of -4.52% from the current stock price of 42.27.
Analyst Consensus: Hold
* Price targets were last updated on Feb 16, 2024.
Analyst Ratings
The average analyst rating for CERE stock from 11 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 1 | 0 | 0 | 0 | 0 |
Buy | 5 | 4 | 2 | 2 | 2 | 2 |
Hold | 5 | 5 | 10 | 10 | 10 | 9 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 12 | 10 | 12 | 12 | 12 | 11 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Mizuho | Mizuho | Hold Maintains $25 → $45 | Hold | Maintains | $25 → $45 | +6.46% | Feb 16, 2024 |
JP Morgan | JP Morgan | Hold Maintains $25 → $45 | Hold | Maintains | $25 → $45 | +6.46% | Dec 28, 2023 |
Jefferies | Jefferies | Strong Buy → Hold Downgrades $40 → $45 | Strong Buy → Hold | Downgrades | $40 → $45 | +6.46% | Dec 22, 2023 |
TD Cowen | TD Cowen | Buy → Hold Downgrades $45 | Buy → Hold | Downgrades | $45 | +6.46% | Dec 8, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $41 → $45 | Strong Buy → Hold | Downgrades | $41 → $45 | +6.46% | Dec 7, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.64
from -2.67
EPS Next Year
-2.84
from -2.64
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 127.1M | 771.1M | 2.0B |
Avg | n/a | n/a | 61.9M | 367.2M | 955.0M |
Low | n/a | n/a | 19.1M | 92.3M | 352.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 1,145.2% | 433.2% |
Avg | - | - | - | 493.0% | 160.0% |
Low | - | - | - | 49.1% | -4.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -2.30 | -2.44 | -2.31 | -1.83 | 0.06 |
Avg | -2.64 | -2.84 | -2.98 | -2.33 | -0.56 |
Low | -3.13 | -3.14 | -3.65 | -3.24 | -0.91 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.